Diet and Nutrition
Arabinogalactan offers no long-term benefits on serum lipids or glucose
Published in Obesity and Diabetes Week, June 21st, 2004
"We conducted a 6-month randomized, double-blind, parallel trial in which subjects consumed their usual diet plus arabinogalactan, a functional fiber isolated from either larch or tamarack. Healthy human subjects (28 men, 26 women) ages 18 to 55 years old consumed 8.4 g/day larch arabinogalactan (n=18), tamarack arabinogalactan (n=19), or a placebo of rice starch (n=17)," scientists writing in the Journal of the American Dietetic Association report.
"Serum cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Therapy
Diabetes in older adults reviewed - Diabetes Therapy
Language used in relation to diabetes may undermine therapy efforts - Endocrinology
Metabolic products measured by NMR analysis of one glucose derivative - Obesity Pathogenesis
Gastrointestinal satiety signals reviewed - Atherosclerosis
PAD patients should be aggressively treated for atherosclerotic risk factors - Business Update
Utah charity files for bankruptcy as probe continues over sale of fitness equipment - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
